| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $722.4M | +51.8% |
| Cost of Revenue | $537.5M | +60.2% |
| Gross Profit | $184.9M | +31.6% |
| R&D Expense | $18.2M | -9.4% |
| SG&A Expense | $55.8M | +49.3% |
| Operating Income | $109.7M | +34.4% |
| Interest Expense | $7.8M | -38.1% |
| Pre-tax Income | $103.4M | +47.2% |
| Income Tax | -$10.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.3M | -25.3% |
| Accounts Receivable | $90.4M | +31.2% |
| Inventory | $127.4M | +35.7% |
| Current Assets | $290.9M | +14.4% |
| Total Assets | $424.7M | +29.4% |
| Current Liabilities | $92.3M | -59.5% |
| Long-term Debt | $10K | -73.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.1M | -61.4% |
| Capital Expenditures | $10.0M | +118.8% |
| Investing Cash Flow | -$10.0M | -118.5% |
| Financing Cash Flow | -$27.7M | -6.8% |
| Free Cash Flow | $14.1M | -75.5% |
| -1252.2% |
| Net Income | $114.0M | +64.5% |
| EPS (Basic) | $4.95 | +64.5% |
| EPS (Diluted) | $4.94 | +64.1% |
| Total Liabilities |
| $246.1M |
| -6.4% |
| Stockholders' Equity | $178.6M | +173.7% |